Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention
Yeh RW, Normand S-LT, et al.
Background: Drug-eluting stents (DES) for percutaneous coronary intervention decrease the risk of restenosis compared with bare metal stents. However, they are costlier, require prolonged dual antiplatelet therapy, and provide the most benefit in patients at highest risk for restenosis. To assist physicians in targeting DES use in patients at the highest risk for target vessel revascularization (TVR), we developed and validated a model to predict TVR.
Improvement in Mortality Risk Prediction After Percutaneous Coronary Intervention Through the Addition of a “Compassionate Use” Variable to the National Cardiovascular Data Registry CathPCI Dataset: A Study From the Massachusetts Angioplasty Registry Resnic FS, Normand S-LT, Piemonte TC, Shubrooks SJ, Zelevinsky K, Lovett A, Ho KKL Journal of the American College of Cardiology, Year: 2011, […]
Editorial: The Need for “Compassionate Provider Profiling”: Refining Risk Assessment for Percutaneous Coronary Intervention
Peterson ED Journal of the American College of Cardiology, Year: 2011, Volume: 57, Pages: 912-913. Link to publication In today’s “transparent” society, the public is increasingly demanding more information on the quality and outcomes of medical care. Most would agree that patients need more data regarding their health care providers’ results, yet the devil is […]
Long-term Clinical Outcomes Following Drug-Eluting or Bare-Metal Stent Placement in Patients With Severely Reduced GFR:…
Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry Charytan, DM, Varma,MR, Silbaugh, TS, Lovett, AF, Normand, S-LT, Mauri, L American Journal of Kidney Diseases, Year: 2011, Volume: 57, Pages: 202-211. Link to publication Background: Patients with chronic kidney disease have been under-represented in randomized trials of drug-eluting stents relative to bare-metal stents and […]
Impact of Independent Data Adjudication on Hospital-Specific Estimates of Risk-Adjusted Mortality Following Percutaneous Coronary Interventions in Massachusetts
Barringhaus KG, Zelevinsky K, Lovett A, Normand S-LT, Ho KKL Circulation: Cardiovascular Quality and Outcomes, Year: 2011, Volume: 4, Pages: 92-98. Link to publication Background— As part of state-mandated public reporting of outcomes after percutaneous coronary interventions (PCIs) in Massachusetts, procedural and clinical data were prospectively collected. Variables associated with higher mortality were audited to […]